NCT03590457

Brief Summary

Background: High-flow nasal cannula (HFNC) is a non-invasive heated and humidified oxygen delivery device that is capable of delivering high-flow rates. It is a relatively new modality that has been introduced as an alternative to conventional oxygen therapy. The clinical value of the use of HFNC is not limited to its ventilation and oxygenation effects, it enables the patient to talk and is purported to permit oral feeding during oxygen therapy despite the limited evidence regarding its impact on swallow function. This study will determine the impact of different flow rates of a high-flow nasal cannula on spontaneous swallowing frequency at rest and swallowing effort and timing while swallowing. Methods: This is a prospective study designed to measure swallowing frequency and swallowing effort in fifty healthy adult volunteers. Participants will receive three levels of HFNC flow rates (30, 45, and 60 L/min) through nasal prongs. The study participants will be asked to swallow measured amounts of water and applesauce and subjected to each flow rate for 15 minutes. Swallowing effort measurement through surface electromyography (sEMG) will be recorded at baseline and the three levels of HFNC flow rates interventions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 22, 2018

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

June 26, 2018

Completed
22 days until next milestone

First Posted

Study publicly available on registry

July 18, 2018

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2019

Completed
2.8 years until next milestone

Results Posted

Study results publicly available

September 27, 2022

Completed
Last Updated

September 27, 2022

Status Verified

August 1, 2022

Enrollment Period

1.4 years

First QC Date

June 26, 2018

Results QC Date

August 6, 2022

Last Update Submit

August 31, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Swallow Frequency Recorded by Surface Electromyography (sEMG)

    Number of swallows

    each swallow frequency exam took 1 minute, exams were done for each flow rate which took up to 2 hours to complete

Study Arms (1)

High-Flow/Swallow

OTHER

All participants will be subjected to all three flows randomly. All participants will be asked swallow water and applesauce

Device: Airvo 2; High-Flow nasal cannula system

Interventions

Noninvasive device used to deliver humidified oxygen at high flow rates up to 60 liters per minute

High-Flow/Swallow

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age or older
  • No cognitive impairments

You may not qualify if:

  • Less than 21 years old
  • History of swallow dysphagia
  • History of disease/condition that may cause dysphagia
  • Use of medications that may alter swallow function
  • Nasal obstruction
  • Presence of tracheostomy tube

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rush University Medical Center

Chicago, Illinois, 60187, United States

Location

MeSH Terms

Conditions

Deglutition DisordersRespiratory Insufficiency

Condition Hierarchy (Ancestors)

Esophageal DiseasesGastrointestinal DiseasesDigestive System DiseasesPharyngeal DiseasesOtorhinolaryngologic DiseasesRespiration DisordersRespiratory Tract Diseases

Results Point of Contact

Title
Dr. Brady Scott
Organization
Rush University

Study Officials

  • Jonathan B Scott, PhD

    Rush University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor, Director of Clinical Education

Study Record Dates

First Submitted

June 26, 2018

First Posted

July 18, 2018

Study Start

June 22, 2018

Primary Completion

December 1, 2019

Study Completion

December 1, 2019

Last Updated

September 27, 2022

Results First Posted

September 27, 2022

Record last verified: 2022-08

Data Sharing

IPD Sharing
Will not share

Locations